HIF1A and melanoma: Inhibiting the transcriptional activities of HIF-1α increases NK cells and CTLs mediated by CCL2- and CCL5 in the tumor bed in a murine melanoma model, thus enhancing the anticancer effects of peptide vaccine and anti-PD-1 blocking antibodies [69].